BioTelemetry (BEAT) Tops Q1 EPS by 16c

BioTelemetry (NASDAQ: BEAT) reported Q1 EPS of $0.39, $0.16 better than the analyst estimate of $0.23. Revenue for the quarter came in at $94.5 million versus the consensus estimate of $91.58 million.

For earnings history and earnings-related data on BioTelemetry (BEAT) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Evercore ISI on Jersey Mike's Subs (JMKE): 'Anticipating a positive outlook'
• Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco